Pfizer
United Kingdom
ROLE SUMMARY The Global Development Lead (GDL), Internal Medicine RU (IMRU) will be the thought leader driving clinical research for the expanding area of cardiometabolic diseases at Pfizer. The candidate will be responsible for creating the overarching strategy for early clinical development programs with a focus on innovative design, medical and scientific excellence, and the highest ethical standards. The candidate will lead clinical development strategy and program execution of research projects with a particular focus on cardiometabolic diseases and associated conditions (e.g., cardiovascular disease, heart failure, renal impairment, obesity, diabetes, etc.), and lead translation of pre-clinical observations into clinical experiments and Phase 1/2 studies designed to demonstrate proof of pharmacology, proof of mechanism and proof of concept for new candidate medicines. The GDL will apply deep medical and clinical knowledge to translate clinical research ideas into...
